Advertisement

Topics

Jaguar Média Inc. Company Profile

18:31 EST 9th December 2018 | BioPortfolio

Nil

Location

1160, rue de Lévis, 100
Lachenaie
Quebec
J6W 5S6
Canada

Contact

Phone: 450.471.7599
Fax: 450-471-5443
Email: info@jaguar-media.com


News Articles [17 Associated News Articles listed on BioPortfolio]

Jaguar Health, Inc.: Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering

SAN FRANCISCO, CA / ACCESSWIRE / October 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceutical company focused on developing novel, sustainabl...

Jaguar Health, Inc.: Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors

Separately, Jaguar has received notification that the Company is now in compliance with NASDAQ's listing standards SAN FRANCISCO, CA / ACCESSWIRE / June 20, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX...

Jaguar Health, Inc.: Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors

SAN FRANCISCO, CA / ACCESSWIRE / June 18, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products pharmaceutical company focused on developing nov...

Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida

SAN FRANCISCO, CA / ACCESSWIRE / October 24, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceutical company focused on developing novel, sustainabl...

Jaguar Mining Reports Third Quarter 2018 Financial Results and Announces Changes to Board of ...

TSX: JAG TORONTO, Nov. 14, 2018 /PRNewswire/ - Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX: JAG) today announced financial results for the third quarter Read more...

Jaguar Health, Inc. Provides Second Quarter 2018 Financial Updates

Napo Pharmaceuticals, Inc., Jaguar's wholly-owned human health subsidiary, achieved 47% gross sales growth for Mytesi® (crofelemer) in the second quarter of 2018 versus the first quarter of 2018 SA.....

Jaguar Health, Inc.: Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product

RedHill (NASDAQ: RDHL) has been granted the exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release tablets) to certain gastroenterologists and primary care physicians for the app...

Jaguar Animal Health, Inc. (JAGX) CEO Lisa Conte on Q3 2018 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Conservation implications for jaguars and other neotropical mammals using highway underpasses.

The Nuevo Xcan-Playa del Carmen highway in Quintana Roo, bisects the vegetation corridor connecting two Jaguar Conservation Units (JCUs): Yum Balaam (north) and Sian Ka´an (south). The project´s mai...

Jaguar movement database: a GPS-based movement dataset of an apex predator in the Neotropics.

The field of movement ecology has rapidly grown during the last decade, with important advancements in tracking devices and analytical tools that have provided unprecedented insights into where, when,...

Pyridyl thiosemicarbazide: synthesis, crystal structure, DFT/B3LYP, molecular docking studies and its biological investigations.

N-(pyridin-2-yl)hydrazinecarbothioamide has been synthesized and characterized by single-crystal X-ray and spectroscopic techniques. Furthermore, its geometry optimization, calculated vibrational freq...

Jaguar and puma captivity and trade among the Maya: Stable isotope data from Copan, Honduras.

From Moctezuma's zoo to animals kept in captivity at Teotihuacan, there is increasing evidence that Mesoamericans managed wild animals for a myriad of purposes. The present study situates ritualized a...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Sono-ease Device for Internal Jaguar Vein Cannulation

A novel device attached to ultrasound probe designed to increase success rate and safety of internal jugular vein cannulation.

Companies [6 Associated Companies listed on BioPortfolio]

Jaguar Animal Health, Inc.

Jaguar is focused on the development and commercialization of health solutions for the global veterinary marketplace from plants used traditionally in rain forest areas. Jaguarâ...

Jaguar Média Inc.

Nil

Jaguar Health, Inc.

Jaguar Health, Inc. is a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human pre...

Ford Motor Company

Ford Motor Company, a global automotive industry leader based in Dearborn, Mich., manufactures and distributes automobiles in 200 markets across six continents. With about 300,000 employees and 108 pl...

Labfacility Ltd

Formed in 1971, Labfacility specialises in the field of Temperature and Process Measurement.Our major UK blue-chip clients include BAE, Eurotherm, GlaxoSmithKline, H J Heinz, Honeywell Control Systems...

More Information about "Jaguar Média Inc." on BioPortfolio

We have published hundreds of Jaguar Média Inc. news stories on BioPortfolio along with dozens of Jaguar Média Inc. Clinical Trials and PubMed Articles about Jaguar Média Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jaguar Média Inc. Companies in our database. You can also find out about relevant Jaguar Média Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record